Concepedia

Ed Lemmens

EL

Statistics

Publications

9

Citations

944

H-Index

9

Active since

2010

Affiliations

Sidney Kimmel Comprehensive Cancer Center(Current)

Aduro BioTech (United States)

Moffitt Cancer Center

University of California, San Francisco

National Cancer Institute

Ed Lemmens is an author at Sidney Kimmel Comprehensive Cancer Center specializing in oncology, immunology, and cancer immunotherapy.

Publications per year

2010–2020

9

Publications

9

Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi et al. · Journal of Clinical Oncology · 2015 · 600 citations

, , +17

Clinical Response of Live-Attenuated, <i>Listeria monocytogenes</i> Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma

Raffit Hassan, Evan Alley, Hedy L. Kindler et al. · Clinical Cancer Research · 2019 · 127 citations · Full text

, , +11

RasGRP1 opposes proliferative EGFR–SOS1–Ras signals and restricts intestinal epithelial cell growth

Philippe Depeille, Linda M. Henricks, Robert A. H. van de Ven et al. · Nature Cell Biology · 2015 · 75 citations · Full text

, , +12

Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis

Ming Yang, Christopher C. Govern, Arup K. Chakraborty et al. · DSpace@MIT (Massachusetts Institute of Technology) · 2012 · 53 citations · Full text

, , +14

A phase 2, randomized trial of GVAX pancreas and CRS-207 immunotherapy versus GVAX alone in patients with metastatic pancreatic adenocarcinoma: Updated results.

Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi et al. · Journal of Clinical Oncology · 2014 · 30 citations

, , +17

1–5 of 9